Xylem (XYL) Reports In-Line Q3 EPS, provides guidance

Xylem (NYSE: XYL) reported Q3 EPS of $1.11, in-line with the analyst estimate of $1.11. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.17 billion.

GUIDANCE:

Xylem sees FY2024 EPS of $4.22-$4.24, versus the consensus of $4.26. Xylem sees FY2024 revenue of $8.5 billion, versus the consensus of $8.582 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Pfizer reaffirms 2026 guidance after CFO transition news
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS